1Zheng Z, Pan J, Chu B, et al. Downregulation and abnonnol expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma : close association with advanced disease stage and lymph node metastasis [J].Hum Pathol, 1999.30(4) :458-466.
2Huang GW, Mo WN, Kuang GQ, et al. Expression of p16, nm23H1, Ecadherin, and CD.t gene products and their significance in nasopharyngem carcinoma[J] . Laryngoscope, 2001,111 (8) : 1465-1471.
3Bukmdm IK, Nesland JM, Kanesen B, et at. Expression of E-cadhefin and its relation to the p53 protein status in human breast carcinoma[J] . Virchours Arch, 1997,431(2) :317-321.
4Nakopoulou L, Gakiopoulou H, Keramopoulos A, et al. c-Met tyrosine kinase receptor expression is associated with abnormal -catenin expression and favourable prognostic factors in invasive breast carcinoma[J].Histopathology, 2000,36 ( 4 ) : 313-325.
6Lim SC, Lee MS. Significance of E-cadherin/beta-catenin compliex and cyclin D1 in breast cancer [J]. Oncol Rep,2002,9(5):915-928.
7Hidaka N, Nagao Y, Asoh A, et al. Expression of E-cadhefin alphacatenin and gamma-catenin in bronchioloalvelar carcinoma and convenional pulmonary adenocarcinoma: an immunohistochemical study [ J ].Mod Pathol, 1998,1(6) : 1039-1045.
9Cioftl M, Gazzerro P, Finizio BD, et al. Serum-soluble E-cadher in fragments in lung cancer[J]. Turnoff, 1999,85 ( 1 ) : 32-34.
10Brenmes RM, Veve B, Gabfielson E, et al. Hight-throughput tissue microarray used to the E-cadherin pathway in non-small-cen lung cancer[J] .J Clin Oncol,2002,20(10) :2417-2428.
3Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis[J] .Lab Inves, 1993,68(1):4-17.
4Carbognani P, Spaggiari L, Romani A, et al. Express of human CD44 V6 in non-small cell lung cancer[J]. Eur Surg Res, 1998, 30 (6): 403-408.
5Miyoshi T, Kondo K, Hino N, et al. The expression of the CD44 variant exon 6 is associated with lyrmph node metastatasis in non-small cell lung cancer[J]. Clin Cancer Res, 1997,3(8): 1289-1297.
6Takigawa N,Segawa Y,Mandai K, et al.Serum CD44 levels in patients with non-small cell lung carcinomas and their relationship with clinicopathological features[J]. Lung Cancer, 1997,18(2): 147-157.
7Kim YJ,Borsig L,Varki NM, et al .P-selectin deficiency attenuates mmor growth and metastasis[J].Prnc Natl Acad Sci USA, 1998,95(16):9325-9330.
8Osaki T, Mitsudomi T, Yoshida Y, et al. Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer[J]. Surg Oncol, 1996,5(3): 107-113.
9Schardt C, Heymanns J, Rotsch M, et al. Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types[J]. Eur J Cancer, 1993,29(16) :2250-2255.
10Grothey A,Heistermann P, Philippou S, et al. Serum levels of soluble intercellular adhesion molecttle-1 (ICAM-1, CD54 ) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage[J]. Br J Cancer, 1998,77(5) :801-807.